ECM Therapeutics, Inc. is a regenerative medicine company that develops and manufactures therapeutic products derived from a naturally occurring material called extracellular matrix (ECM).
Extracellular matrix is a naturally occurring reservoir of potent signaling molecules within all tissues and has the ability to influence cell behavior, control inflammation, and promote the restoration of functional tissue following injury.
Dr. Stephen Badylak's laboratory is a world-renowned and highly interdisciplinary environment focused on developing regenerative medicine strategies that address significant clinical needs.
Extensive bench-top laboratory work, preclinical animal studies, human clinical experience with alternative forms of ECM-based materials, scientific publications, and an extensive patent portfolio have strategically positioned ECM Therapeutics to develop products in a number of different clinical markets including the gastrointestinal, musculoskeletal, optic and central nervous system.
This review highlights the fundamental characteristics of EVs, the current pre-clinical and clinical applications of EVs in TERM, and the future of EV-based strategies in TERMRead More
The native mammalian ECM constitutes an ideal microenvironmental niche for functional tissue reconstruction. The ECM contains intrinsic biochemical and mechanical cues that regulate cell phenotype and function in development, in homeostasis and in response to injury.Read More
The identification of MBVs embedded within the ECM of biologic scaffolds provides mechanistic insights not only into the inductive properties of ECM bioscaffolds but also into the regulation of tissue homeostasis.Read More
A regenerative medicine company utilizing naturally occurring extracellular matrix based signaling molecules to treat unmet medical needs.
118 Marshall Drive
Warrendale, PA 15086